310 related articles for article (PubMed ID: 24951540)
1. Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtin-induced cell degeneration: involvement of the proteasome and ER stress-activated kinase IRE1α.
Hyrskyluoto A; Bruelle C; Lundh SH; Do HT; Kivinen J; Rappou E; Reijonen S; Waltimo T; Petersén Å; Lindholm D; Korhonen L
Hum Mol Genet; 2014 Nov; 23(22):5928-39. PubMed ID: 24951540
[TBL] [Abstract][Full Text] [Related]
2. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
[TBL] [Abstract][Full Text] [Related]
3. USP14 inhibits ER-associated degradation via interaction with IRE1alpha.
Nagai A; Kadowaki H; Maruyama T; Takeda K; Nishitoh H; Ichijo H
Biochem Biophys Res Commun; 2009 Feb; 379(4):995-1000. PubMed ID: 19135427
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
Díaz-Hernández M; Valera AG; Morán MA; Gómez-Ramos P; Alvarez-Castelao B; Castaño JG; Hernández F; Lucas JJ
J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406
[TBL] [Abstract][Full Text] [Related]
5. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
[TBL] [Abstract][Full Text] [Related]
6. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.
Chiang MC; Chen HM; Lai HL; Chen HW; Chou SY; Chen CM; Tsai FJ; Chern Y
Hum Mol Genet; 2009 Aug; 18(16):2929-42. PubMed ID: 19443488
[TBL] [Abstract][Full Text] [Related]
7. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
Luo H; Cao L; Liang X; Du A; Peng T; Li H
Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease.
Hunter JM; Lesort M; Johnson GV
J Neurosci Res; 2007 Jun; 85(8):1774-88. PubMed ID: 17455294
[TBL] [Abstract][Full Text] [Related]
9. The Ubiquitin Receptor ADRM1 Modulates HAP40-Induced Proteasome Activity.
Huang ZN; Her LS
Mol Neurobiol; 2017 Nov; 54(9):7382-7400. PubMed ID: 27815841
[TBL] [Abstract][Full Text] [Related]
10. ENC1 Modulates the Aggregation and Neurotoxicity of Mutant Huntingtin Through p62 Under ER Stress.
Lee H; Ahn HH; Lee W; Oh Y; Choi H; Shim SM; Shin J; Jung YK
Mol Neurobiol; 2016 Dec; 53(10):6620-6634. PubMed ID: 26637326
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of p38 Mitogen-Activated Protein Kinase Ameliorates HAP40 Depletion-Induced Toxicity and Proteasomal Defect in Huntington's Disease Model.
Huang ZN; Chen JM; Huang LC; Fang YH; Her LS
Mol Neurobiol; 2021 Jun; 58(6):2704-2723. PubMed ID: 33492644
[TBL] [Abstract][Full Text] [Related]
12. Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice.
Wang J; Wang CE; Orr A; Tydlacka S; Li SH; Li XJ
J Cell Biol; 2008 Mar; 180(6):1177-89. PubMed ID: 18362179
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease.
Wang CE; Tydlacka S; Orr AL; Yang SH; Graham RK; Hayden MR; Li S; Chan AW; Li XJ
Hum Mol Genet; 2008 Sep; 17(17):2738-51. PubMed ID: 18558632
[TBL] [Abstract][Full Text] [Related]
14. Small molecule modulator of protein disulfide isomerase attenuates mutant huntingtin toxicity and inhibits endoplasmic reticulum stress in a mouse model of Huntington's disease.
Zhou X; Li G; Kaplan A; Gaschler MM; Zhang X; Hou Z; Jiang M; Zott R; Cremers S; Stockwell BR; Duan W
Hum Mol Genet; 2018 May; 27(9):1545-1555. PubMed ID: 29462355
[TBL] [Abstract][Full Text] [Related]
15. TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models.
Hegde RN; Chiki A; Petricca L; Martufi P; Arbez N; Mouchiroud L; Auwerx J; Landles C; Bates GP; Singh-Bains MK; Dragunow M; Curtis MA; Faull RL; Ross CA; Caricasole A; Lashuel HA
EMBO J; 2020 Sep; 39(17):e104671. PubMed ID: 32757223
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting the ubiquitin-proteasome system leads to preferential accumulation of toxic N-terminal mutant huntingtin fragments.
Li X; Wang CE; Huang S; Xu X; Li XJ; Li H; Li S
Hum Mol Genet; 2010 Jun; 19(12):2445-55. PubMed ID: 20354076
[TBL] [Abstract][Full Text] [Related]
17. Degradation of mutant huntingtin via the ubiquitin/proteasome system is modulated by FE65.
Chow WN; Luk HW; Chan HY; Lau KF
Biochem J; 2012 May; 443(3):681-9. PubMed ID: 22352297
[TBL] [Abstract][Full Text] [Related]
18. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
[TBL] [Abstract][Full Text] [Related]
19. MnFe
Zhang L; Wei PF; Song YH; Dong L; Wu YD; Hao ZY; Fan S; Tai S; Meng JL; Lu Y; Xue J; Liang CZ; Wen LP
Biomaterials; 2019 Sep; 216():119248. PubMed ID: 31226569
[TBL] [Abstract][Full Text] [Related]
20. Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity.
Khoshnan A; Ko J; Watkin EE; Paige LA; Reinhart PH; Patterson PH
J Neurosci; 2004 Sep; 24(37):7999-8008. PubMed ID: 15371500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
